| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/20/2006 | US20060084661 IL-8 receptor antagonists |
| 04/20/2006 | US20060084660 Calcium channel blockers comprising two benzhydril moieties |
| 04/20/2006 | US20060084659 Augmentation of psychotherapy with cannabinoid reuptake inhibitors |
| 04/20/2006 | US20060084658 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 04/20/2006 | US20060084657 Piperazine derivative |
| 04/20/2006 | US20060084656 Compositions and methods for intranasal, buccal, sublingual and pulmonary delivery of varenicline |
| 04/20/2006 | US20060084655 Reverse-turn mimetics and method relating thereto |
| 04/20/2006 | US20060084654 Imidazopyrazine tyrosine kinase inhibitors |
| 04/20/2006 | US20060084653 Beta-sheet mimetics and composition and methods relating thereto |
| 04/20/2006 | US20060084652 Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 04/20/2006 | US20060084651 Chemical compounds |
| 04/20/2006 | US20060084650 Kinase inhibitors |
| 04/20/2006 | US20060084649 Substituted alkyl amido piperidines |
| 04/20/2006 | US20060084648 Ethynyl derivatives as factor xa inhibitors |
| 04/20/2006 | US20060084647 Small molecule inhibitors of anti-apoptotic BCL-2 family members and the uses thereof |
| 04/20/2006 | US20060084646 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 04/20/2006 | US20060084645 Novel pyrimidine compounds, process for their preparation and compositions containing them |
| 04/20/2006 | US20060084644 Atherosclerosis, unwanted cellular growth or cellular proliferation, diabetes, inflammatory conditions and vascular occlusive pathologic conditions; novel compound 1-[4-(4-Hydroxy-6'-phenyl-3,4,5,6-tetrahydro-2H-[1,4']bipyridinyl-2'-ylamino)-phenyl]-ethanone; modulation of glycosidase enzymes |
| 04/20/2006 | US20060084643 6-Fluoro-10-[3-(2-methoxy-ethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene; dopamine D2 and serotonin receptor anatagonist; neuroleptic agent, antidepressnt; psychological, bipolar disorders, psychosis, schizophrenia, acute mania |
| 04/20/2006 | US20060084642 gamma-aminobutyric acid GABA receptors inverse agonists ; Alzheimer's disease, cognition enhancers; 10-methyl-9H-imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine |
| 04/20/2006 | US20060084641 IL-8 receptor antagonists |
| 04/20/2006 | US20060084640 Vanilloid receptor ligands and their use in treatments |
| 04/20/2006 | US20060084639 Compositions containing piperacillin and tazobactam useful for injection |
| 04/20/2006 | US20060084638 Suppression of an appetite in an individual; can be used to treat individuals who are obese and/or are affected by an obesity-related disorder |
| 04/20/2006 | US20060084637 Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same |
| 04/20/2006 | US20060084636 Methods of using fatty-acid esters of estrogens and serotonin reuptake inhibiting compounds for reducing the body weight of a mammal and compositions containing the same |
| 04/20/2006 | US20060084635 Aspirin and vitamin and/or trace element compositions for the amelioration and treatment of vascular disease |
| 04/20/2006 | US20060084634 treatment of gram positive, gram negative and antibiotic resistant infections; [4(R,S)-(4a alpha ,5a alpha ,12a alpha )]-4-(Dimethylamino)-7-(1H-Tetrazol-1-yl)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide |
| 04/20/2006 | US20060084633 Formulations for treating or preventing mucositis |
| 04/20/2006 | US20060084631 Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof |
| 04/20/2006 | US20060084630 Method for synthesis of beta glucans |
| 04/20/2006 | US20060084629 Immune system activating formula composed of selected long chain polysaccharides from natural sources |
| 04/20/2006 | US20060084628 Combination therapy for treating viral infections |
| 04/20/2006 | US20060084627 Synergistic interaction of abacavir and alovudine |
| 04/20/2006 | US20060084626 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
| 04/20/2006 | US20060084625 Use of A2A adenosine receptor agonists |
| 04/20/2006 | US20060084624 beta-L-2'-deoxy-nucleosides for the treatment of hepatitis B |
| 04/20/2006 | US20060084621 Compositions and methods for inhibiting expression of anti-apoptotic genes |
| 04/20/2006 | US20060084617 Methods for delivery of nucleic acids |
| 04/20/2006 | US20060084616 enzyme inhibitors such as beta-1'-nicotinamide-2'-deoxyribose, used for treating diseases and conditions associated with CD38, related enzymes and cyclic-adenosine-diphosphate-ribose (cADPR) |
| 04/20/2006 | US20060084615 Puerarin derivatives and their medical uses |
| 04/20/2006 | US20060084614 Anticoagulants; bioavailability, lower toxicity; 1-(glycosyl substituted phenylmethylamino)-4-amidino-benzene derivatives |
| 04/20/2006 | US20060084613 Dipeptide enzyme inhibitor; antiinflammatory agents; autoimmune disease; wound healing agents |
| 04/20/2006 | US20060084612 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 04/20/2006 | US20060084595 Complex comprising OCIF and polysaccharide |
| 04/20/2006 | US20060084591 Use of modulators of the signal transduction path using the protein kinase fyn for the treatment of tumorous diseases |
| 04/20/2006 | US20060084590 Methods of and compounds for modulating the activity of bacterial FabG |
| 04/20/2006 | US20060084149 Forming complex in which single-stranded nucleic acid is bound to a double-stranded beta -1,3-glucan which as 1,6-glucopyranoside branch and is chemically modified through periodate oxidation and reductive amination so as to impart nucleic acid-binding functional groups; for use as an antisense agent |
| 04/20/2006 | US20060084143 Screen for agonists and antagonists; treat solid tumors, vascular deficiencies; polypeptide, polynucleotide, plasmid; chemotherapeutic agents, alkylating agents, antimetabolites, vinca alkaloids, plant extracts, nitrosoureas, topoisomerase inhibitors, platinum analogs, adrenocortical suppressants |
| 04/20/2006 | US20060084141 Biosynthetic gene cluster for the maytansinoid antitumor agent ansamitocin |
| 04/20/2006 | US20060084135 Compositions for manipulating the lifespan and stress response of cells and organisms |
| 04/20/2006 | US20060084129 Biosynthesis of lipid class metabolites from pathways of phosphatidylethanolamine-N-methyltransferase, CDP-choline, phosphatidylserine decarboxylase, CDP-ethanolamine or phosphatidylcholine; determining contribution of Acyl-CoA:cholesterol acyltransferase (ACAT) to biosynthesis of cholesterol ester |
| 04/20/2006 | US20060084121 OX2 receptor homologs |
| 04/20/2006 | US20060084118 Lymphocytes; transcription factors; interferons; diagnosis of autoimmune disease such as lupus |
| 04/20/2006 | US20060084109 Regulated aptamer therapeutics |
| 04/20/2006 | US20060084086 Proteins, polynucleotides encoding them and methods of using the same |
| 04/20/2006 | US20060084061 Methods for blocking adipocyte differentiation and triglyceride accumulation with interleukin 12 p35 inhibitors |
| 04/20/2006 | US20060083796 Orally administrable composition for improving hair and coat quality |
| 04/20/2006 | US20060083793 Nutritional composition for promoting muscle performance and acting as hydrogen (H+) blocker |
| 04/20/2006 | US20060083790 Combination of an ibat inhibitor and a metal salt for the treatment of diarrhoea |
| 04/20/2006 | US20060083786 Taste masking pharmaceutical composition containing levocetirizine |
| 04/20/2006 | US20060083785 Large dose ribavirin formulations |
| 04/20/2006 | US20060083784 Amorphous pharmaceutical compositions |
| 04/20/2006 | US20060083783 Treating metabolic syndrome with fenofibrate |
| 04/20/2006 | US20060083779 Diiodothyroacetic acid and method of use |
| 04/20/2006 | US20060083778 Controlled release compositions of estradiol metabolites |
| 04/20/2006 | US20060083774 Neurophilin ligands for treating ocular conditions |
| 04/20/2006 | US20060083759 Stabilization of the profile of release of active substances from a formulation |
| 04/20/2006 | US20060083754 Pharmaceutical combinations comprising corticoids and immunosuppressants for treating corticoid- and/or calcineurin inhibitors-resistant diseases |
| 04/20/2006 | US20060083742 Prenyl-electrostatic switch, and methods of use |
| 04/20/2006 | US20060083740 By modulating the expression of mutant and wild type CD83 gene products produced in a mammal; regulation of T cell and dendritic cell activity; antibodies |
| 04/20/2006 | US20060083739 Treating prostate cancer with anti-ErbB2 antibodies |
| 04/20/2006 | US20060083738 Treatment of cancer by the use of anti fas antibody |
| 04/20/2006 | US20060083734 Composition and method for repairing nerve damage and enhancing functional recovery of nerve |
| 04/20/2006 | US20060083732 Hyaluronic acid in the enhancement of lens regeneration |
| 04/20/2006 | US20060083727 Methods and compositions for the treatment of diseases characterized by calcification and/or plaque formation |
| 04/20/2006 | US20060083724 Compositions for the treatment of femal sexual dysfunction |
| 04/20/2006 | US20060083721 Injectable cross-linked polymeric preparations and uses thereof |
| 04/20/2006 | US20060083714 Combination of a pde iv inhibitor and a tnf-alpha antagonist |
| 04/20/2006 | US20060083711 Methods and products related to the intracellular delivery of polysaccharides |
| 04/20/2006 | US20060083693 Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
| 04/20/2006 | US20060083692 Combination of formoterol and a tiotropium salt |
| 04/20/2006 | US20060083691 Intranasal opioid compositions, delivery devices and methods of using same |
| 04/20/2006 | US20060083686 Therapeutic agent for ulcerative colitis |
| 04/20/2006 | US20060083684 Method of radio-labelling biomolecules |
| 04/20/2006 | US20060083679 Agents with selective K-opioid receptor affinity |
| 04/20/2006 | US20060083676 For marking and identifying metabotropic glutamate receptor sites and for imaging an organ; in particular non-competitive mGlu1 receptor ligands |
| 04/20/2006 | DE202006002355U1 Cosmetic or dermatological preparation, useful for prophylaxis, treatment and care of dry skin, comprises glyceroltriacetate |
| 04/20/2006 | DE20122564U1 Pharmaceutical formulation used for treating edema comprises high purity torsemide modification II |
| 04/20/2006 | DE19830167B4 Neue Azatyrosin-Analoga New azatyrosine analogues |
| 04/20/2006 | DE102005000868A1 Zusammensetzungen mit Inhibitoren der Prostaglandin- und/oder Leukotrien-Synthese in Kombination mit Stimulatoren der Freisetzung kutaner Neuromediatoren Compositions with inhibitors of prostaglandin and / or leukotriene synthesis in combination with stimulators of the release of cutaneous neuromediators |
| 04/20/2006 | DE102004050910A1 Composition containing phospholipid, sterol and negative charge carrier, useful e.g. for treating parasitic diseases and tumors, acts by stimulating leucopoiesis |
| 04/20/2006 | DE102004050353A1 Verwendung stabiler Ammoniumsalze der Liponsäure zur Behandlung diabetischer und weiterer Störungen Using stable ammonium salts of lipoic acid in the treatment of diabetic and other disorders |
| 04/20/2006 | DE102004050196A1 Substituierte 2-Pyridon-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Substituted 2-pyridone derivatives, processes for their preparation and their use as a medicament |
| 04/20/2006 | DE102004049910A1 Composition for photodynamic therapy or diagnosis, useful for treating cancer and skin disorders, comprises chlorin e6, purpurin 5 and poly(vinyl pyrrolidone) |
| 04/20/2006 | DE102004049622A1 Novel para-sulfonamido-substituted 2-anilinopyrimidines are useful in a wide range of medicaments and as cell cycle kinase inhibitors or receptor tyrosine kinase inhibitors |
| 04/20/2006 | DE102004048927A1 Pharmazeutische Kombination enthaltend Desoxypeganin und Cyp2D6 Inhibitoren A pharmaceutical combination comprising deoxypeganine and Cyp2D6 inhibitors |
| 04/20/2006 | DE10127897B4 Manteltablette mit Pflanzentrockenextrakten Coated tablet with dry plant extracts |
| 04/20/2006 | CA2597341A1 Depression of herg k+ channel function in mammalian cells and applications to the control of cancer cells division |
| 04/20/2006 | CA2585832A1 Use of aromatase inhibitors for endometrial thinning in preparation for surgical procedures on the endometrial cavity and uterus |